159 related articles for article (PubMed ID: 21417439)
1. Paclitaxel tumor-priming enhances siRNA delivery and transfection in 3-dimensional tumor cultures.
Wong HL; Shen Z; Lu Z; Wientjes MG; Au JL
Mol Pharm; 2011 Jun; 8(3):833-40. PubMed ID: 21417439
[TBL] [Abstract][Full Text] [Related]
2. Paclitaxel tumor priming promotes delivery and transfection of intravenous lipid-siRNA in pancreatic tumors.
Wang J; Lu Z; Wang J; Cui M; Yeung BZ; Cole DJ; Wientjes MG; Au JL
J Control Release; 2015 Oct; 216():103-10. PubMed ID: 26272765
[TBL] [Abstract][Full Text] [Related]
3. Tumor priming enhances siRNA delivery and transfection in intraperitoneal tumors.
Wang J; Lu Z; Yeung BZ; Wientjes MG; Cole DJ; Au JL
J Control Release; 2014 Mar; 178():79-85. PubMed ID: 24462901
[TBL] [Abstract][Full Text] [Related]
4. Smart polymeric nanoparticles with pH-responsive and PEG-detachable properties for co-delivering paclitaxel and survivin siRNA to enhance antitumor outcomes.
Jin M; Jin G; Kang L; Chen L; Gao Z; Huang W
Int J Nanomedicine; 2018; 13():2405-2426. PubMed ID: 29719390
[TBL] [Abstract][Full Text] [Related]
5. Enhanced Cellular Uptake and Gene Silencing Activity of Survivin-siRNA via Ultrasound-Mediated Nanobubbles in Lung Cancer Cells.
Akbaba H; Erel-Akbaba G; Kotmakçı M; Başpınar Y
Pharm Res; 2020 Aug; 37(8):165. PubMed ID: 32761250
[TBL] [Abstract][Full Text] [Related]
6. Dual-modified cationic liposomes loaded with paclitaxel and survivin siRNA for targeted imaging and therapy of cancer stem cells in brain glioma.
Sun X; Chen Y; Zhao H; Qiao G; Liu M; Zhang C; Cui D; Ma L
Drug Deliv; 2018 Nov; 25(1):1718-1727. PubMed ID: 30269613
[TBL] [Abstract][Full Text] [Related]
7. Tumor priming enhances delivery and efficacy of nanomedicines.
Lu D; Wientjes MG; Lu Z; Au JL
J Pharmacol Exp Ther; 2007 Jul; 322(1):80-8. PubMed ID: 17420296
[TBL] [Abstract][Full Text] [Related]
8. Co-delivery of paclitaxel and anti-survivin siRNA via redox-sensitive oligopeptide liposomes for the synergistic treatment of breast cancer and metastasis.
Chen X; Zhang Y; Tang C; Tian C; Sun Q; Su Z; Xue L; Yin Y; Ju C; Zhang C
Int J Pharm; 2017 Aug; 529(1-2):102-115. PubMed ID: 28642204
[TBL] [Abstract][Full Text] [Related]
9. [Relationship between survivin expression and chemosensitivity of human lung cancer cells].
Yang H; Fu JH; Hu Y; Huang WZ; Zheng B; Wang G
Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(27):1934-7. PubMed ID: 17923022
[TBL] [Abstract][Full Text] [Related]
10. Multifunctional Polymeric Micelles Co-loaded with Anti-Survivin siRNA and Paclitaxel Overcome Drug Resistance in an Animal Model of Ovarian Cancer.
Salzano G; Navarro G; Trivedi MS; De Rosa G; Torchilin VP
Mol Cancer Ther; 2015 Apr; 14(4):1075-84. PubMed ID: 25657335
[TBL] [Abstract][Full Text] [Related]
11. A new strategy in the treatment of chemoresistant lung adenocarcinoma via specific siRNA transfection of SRF, E2F1, Survivin, HIF and STAT3.
Stoleriu MG; Steger V; Mustafi M; Michaelis M; Cinatl J; Schneider W; Nolte A; Kurz J; Wendel HP; Schlensak C; Walker T
Eur J Cardiothorac Surg; 2014 Nov; 46(5):877-86. PubMed ID: 24627437
[TBL] [Abstract][Full Text] [Related]
12. Cluster of Differentiation 44 Targeted Hyaluronic Acid Based Nanoparticles for MDR1 siRNA Delivery to Overcome Drug Resistance in Ovarian Cancer.
Yang X; Iyer AK; Singh A; Milane L; Choy E; Hornicek FJ; Amiji MM; Duan Z
Pharm Res; 2015 Jun; 32(6):2097-109. PubMed ID: 25515492
[TBL] [Abstract][Full Text] [Related]
13. Tumor-penetrating codelivery of siRNA and paclitaxel with ultrasound-responsive nanobubbles hetero-assembled from polymeric micelles and liposomes.
Yin T; Wang P; Li J; Wang Y; Zheng B; Zheng R; Cheng D; Shuai X
Biomaterials; 2014 Jul; 35(22):5932-43. PubMed ID: 24746965
[TBL] [Abstract][Full Text] [Related]
14. Synergistic effect of survivin-specific small interfering RNA and topotecan in renal cancer cells: topotecan enhances liposome-mediated transfection by increasing cellular uptake.
Sato A; Ito K; Asano T; Sumitomo M; Asano T; Hayakawa M
Int J Oncol; 2007 Mar; 30(3):695-700. PubMed ID: 17273771
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and Characterization of a New Cationic Lipid: Efficient siRNA Delivery and Anticancer Activity of Survivin-siRNA Lipoplexes for the Treatment of Lung and Breast Cancers.
Vaidya S; Mohod A; Eedara AC; Andugulapati SB; Pabbaraja S
ChemMedChem; 2023 Aug; 18(16):e202300097. PubMed ID: 37306531
[TBL] [Abstract][Full Text] [Related]
16. Reversal of lung cancer multidrug resistance by pH-responsive micelleplexes mediating co-delivery of siRNA and paclitaxel.
Yu H; Xu Z; Chen X; Xu L; Yin Q; Zhang Z; Li Y
Macromol Biosci; 2014 Jan; 14(1):100-9. PubMed ID: 23966347
[TBL] [Abstract][Full Text] [Related]
17. Delivery of siRNA Using Cationic Liposomes Incorporating Stearic Acid-modified Octa-Arginine.
Yang D; Li Y; Qi Y; Chen Y; Yang X; Li Y; Liu S; Lee RJ
Anticancer Res; 2016 Jul; 36(7):3271-6. PubMed ID: 27354583
[TBL] [Abstract][Full Text] [Related]
18. Intravenous siRNA Silencing of Survivin Enhances Activity of Mitomycin C in Human Bladder RT4 Xenografts.
Cui M; Au JL; Wientjes MG; O'Donnell MA; Loughlin KR; Lu Z
J Urol; 2015 Jul; 194(1):230-7. PubMed ID: 25681288
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of survivin enhances paclitaxel-induced Hela cell apoptosis.
Gu F; Li L; Yuan QF; Li C; Li ZH
Eur Rev Med Pharmacol Sci; 2017 Aug; 21(15):3504-3509. PubMed ID: 28829489
[TBL] [Abstract][Full Text] [Related]
20. Polymeric micelles containing reversibly phospholipid-modified anti-survivin siRNA: a promising strategy to overcome drug resistance in cancer.
Salzano G; Riehle R; Navarro G; Perche F; De Rosa G; Torchilin VP
Cancer Lett; 2014 Feb; 343(2):224-31. PubMed ID: 24099916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
